DoseCraft
VapeHeatLab
About
Cara Cara #8 is a hybrid cannabis strain. Lab samples test between 21.8% and 29.5% THC, with caryophyllene (0.50%) as the dominant terpene.
Why does Cara Cara #8 feel pain-relieving?
Cara Cara #8's pain-relieving effects are linked to its dominant caryophyllene (0.50%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by humulene (0.29%), associated with appetite suppression and anti-inflammatory effects.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool's sedative properties may aid sleep
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- Genetics
- GMO × Mimosa
- THC
- 21.8–29.5%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout Cara Cara #8
- Cara Cara #8 is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- Cara Cara #8 typically tests at 21.8% to 29.5% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
- The dominant terpenes in Cara Cara #8 are Caryophyllene, Humulene, Myrcene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.
- Cara Cara #8 is a cross of GMO and Mimosa.